Pharm Sci’s Robert Spitale wins Ono Pharma Breakthrough Science Initiative Award

Pharm Sci’s Robert Spitale wins Ono Pharma Breakthrough Science Initiative Award

Robert Spitale, associate professor of pharmaceutical sciences, is one of five winners of 2019 Ono Pharma Breakthrough Science Initiative Awards, intended to accelerate high-risk and high-reward science research projects that could lead to discoveries, solutions and potential breakthrough treatments for patients. The award is for three years and provides $900,000 in direct funds for selected projects. Spitale’s is titled “Imaging and Genetically Characterizing Tumors With PET-Seq.” He will work to better understand the mechanics of positron emission tomography imaging. “PET imaging is routinely used by radiologists, oncologists and surgeons to guide treatment regimens or surgical resection,” Spitale said. “Despite the widespread use of PET imaging, it suffers from several drawbacks that, if improved, would have a tremendous effect on implementation, interpretation and utilization of these signals and guide patient therapy. About 2,500 PET scanners perform about 2 million scans per year; as such, the impact of our proposed studies could be very far-reaching.”

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

0 Shares
Share
Tweet
Share